204 related articles for article (PubMed ID: 7915911)
1. Critical determination of the frequency of c-erbB-2 amplification in breast cancer.
Hubbard AL; Doris CP; Thompson AM; Chetty U; Anderson TJ
Br J Cancer; 1994 Sep; 70(3):434-9. PubMed ID: 7915911
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of c-erbB-2 amplification in breast carcinoma by differential polymerase chain reaction.
Gramlich TL; Cohen C; Fritsch C; DeRose PB; Gansler T
Am J Clin Pathol; 1994 Apr; 101(4):493-9. PubMed ID: 7909190
[TBL] [Abstract][Full Text] [Related]
3. Measuring c-erbB-2 oncogene amplification in fresh and paraffin-embedded tumors by competitive polymerase chain reaction.
Sestini R; Orlando C; Zentilin L; Gelmini S; Pinzani P; Bianchi S; Selli C; Giacca M; Pazzagli M
Clin Chem; 1994 Apr; 40(4):630-6. PubMed ID: 7511998
[TBL] [Abstract][Full Text] [Related]
4. c-erbB-2 amplification in breast cancer: detection in formalin-fixed, paraffin-embedded tissue by in situ hybridization.
Smith KL; Robbins PD; Dawkins HJ; Papadimitriou JM; Redmond SL; Carrello S; Harvey JM; Sterrett GF
Hum Pathol; 1994 Apr; 25(4):413-8. PubMed ID: 7909307
[TBL] [Abstract][Full Text] [Related]
5. Comparison of differential PCR and immunohistochemistry for the evaluation of c-erbB-2 in breast carcinoma and relationship to other prognostic factors.
Erdogan S; Ergin M; Tuncer I
Neoplasma; 2003; 50(5):326-30. PubMed ID: 14628084
[TBL] [Abstract][Full Text] [Related]
6. What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease.
Dawkins HJ; Robbins PD; Smith KL; Sarna M; Harvey JM; Sterrett GF; Papadimitriou JM
Pathol Res Pract; 1993 Dec; 189(10):1233-52. PubMed ID: 7910395
[TBL] [Abstract][Full Text] [Related]
7. Assessment of c-erbB-2 amplification by immunohistochemistry in paraffin-embedded breast cancer.
Kerns BJ; Jordan PA; Huper G; Marks JR; Iglehart JD; Layfied LJ
Mod Pathol; 1993 Nov; 6(6):673-8. PubMed ID: 7905629
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of the overexpression of c-erbB-2 protein in adenocarcinoma of the uterine cervix.
Kihana T; Tsuda H; Teshima S; Nomoto K; Tsugane S; Sonoda T; Matsuura S; Hirohashi S
Cancer; 1994 Jan; 73(1):148-53. PubMed ID: 7506116
[TBL] [Abstract][Full Text] [Related]
9. Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer.
Lemoine NR; Jain S; Silvestre F; Lopes C; Hughes CM; McLelland E; Gullick WJ; Filipe MI
Br J Cancer; 1991 Jul; 64(1):79-83. PubMed ID: 1677259
[No Abstract] [Full Text] [Related]
10. Amplification of erbB-4 oncogene occurs less frequently than that of erbB-2 in primary human breast cancer.
Vogt U; Bielawski K; Schlotter CM; Bosse U; Falkiewicz B; Podhajska AJ
Gene; 1998 Nov; 223(1-2):375-80. PubMed ID: 9858771
[TBL] [Abstract][Full Text] [Related]
11. Detection of HER-2 oncogene amplification in breast cancer by differential polymerase chain reaction from single cryosections.
Friedrichs K; Lohmann D; Höfler H
Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 64(4):209-12. PubMed ID: 7904515
[TBL] [Abstract][Full Text] [Related]
12. Reliability of differential PCR for the detection of EGFR and MDM2 gene amplification in DNA extracted from FFPE glioma tissue.
Hunter SB; Abbott K; Varma VA; Olson JJ; Barnett DW; James CD
J Neuropathol Exp Neurol; 1995 Jan; 54(1):57-64. PubMed ID: 7815080
[TBL] [Abstract][Full Text] [Related]
13. Detection of c-erbB-2/neu and fibroblast growth factor-3/INT-2 but not epidermal growth factor receptor gene amplification in endometrial cancer by differential polymerase chain reaction.
Esteller M; García A; Martínez i Palones JM; Cabero A; Reventós J
Cancer; 1995 Apr; 75(8):2139-46. PubMed ID: 7697605
[TBL] [Abstract][Full Text] [Related]
14. Reduction of telomeric length and c-erbB-2 gene amplification in human breast cancer, fibroadenoma, and gynecomastia. Relationship to histologic grade and clinical parameters.
Odagiri E; Kanada N; Jibiki K; Demura R; Aikawa E; Demura H
Cancer; 1994 Jun; 73(12):2978-84. PubMed ID: 7911069
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of ErbB-2 protein in tissue extract using an enzyme immuno assay (ErbB-2 EIA "Nichirei")].
Sugano K; Kitajima M; Ishii M; Koyama H; Kasumi F; Demura R; Mori S; Ohkura H
Gan To Kagaku Ryoho; 1994 Sep; 21(12):1957-66. PubMed ID: 7916182
[TBL] [Abstract][Full Text] [Related]
16. The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast.
Liu E; Thor A; He M; Barcos M; Ljung BM; Benz C
Oncogene; 1992 May; 7(5):1027-32. PubMed ID: 1349163
[TBL] [Abstract][Full Text] [Related]
17. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA
Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study on overexpression of c-erbB-2 protein in human breast cancer: its correlation with gene amplification and long-term survival of patients.
Tsuda H; Hirohashi S; Shimosato Y; Tanaka Y; Hirota T; Tsugane S; Shiraishi M; Toyoshima K; Yamamoto T; Terada M
Jpn J Cancer Res; 1990 Apr; 81(4):327-32. PubMed ID: 1973161
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer: prognostic significance of c-erb-B2 and int-2 amplification compared with DNA ploidy, S-phase fraction, and conventional clinicopathological features.
Lönn U; Lönn S; Nilsson B; Stenkvist B
Breast Cancer Res Treat; 1994; 29(3):237-45. PubMed ID: 7914106
[TBL] [Abstract][Full Text] [Related]
20. A comparison of epidermal growth factor receptor (EGFR) and c-erbB-2 oncogene expression in head and neck squamous cell carcinomas.
Kearsley JH; Leonard JH; Walsh MD; Wright GR
Pathology; 1991 Jul; 23(3):189-94. PubMed ID: 1685773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
